October 9th, 2020

Bone Cancer Awareness Week 2020

12 – 18 October 2020

76% of primary bone cancer cases in the UK are misdiagnosed. #BoneCancerAwareness Week 2020 is all about educating GPs, Radiologists, Physiotherapists, Pharmacists and Medical Students about the…

October 5th, 2020

Free educational webinars for healthcare professionals

Register for our free webinars now.

76% of primary bone cancer cases in the UK are misdiagnosed. Throughout Bone Cancer Awareness Week (12 – 18 Oct) we are holding a series of FREE webinars,…

October 1st, 2020

Straight Talk About Chondrosarcoma

A Virtual Dialogue (Via Zoom)

Tuesday, November 17, 2020

7:30pm – 8:30pm EST

1. Progress Report:

So far we have 38 Chondrosarcoma Warrior’s and their families registered and many of the registrant’s have…

September 19th, 2020

Hello my CS brothers and sisters! I wanted to tell you a story about my journey which might help some of you. Here are some details:

–diagnosed in Feb 2017, Grade 1 pelvic CS, spread widely on and around the acetabulum. Offered a hemipelvectomy…

September 10th, 2020

On Tuesday, November 17, 2020 from 7:30pm -8:30pm, the Chondrosarcoma CS Foundation, Inc. will host a virtual dialogue using the zoom platform to reach out to sarcoma experts, and oncologists as well as patients diagnosed with Chondrosarcoma and…

September 8th, 2020

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

https://clinicaltrials.gov/ct2/show/NCT03715933?term=DR5+INBRX109&rank=1

Go to

Arm
Intervention/treatment

Experimental: Dose…

September 5th, 2020

Hello my CS brothers and sisters! I wanted to tell you a story about my journey which might help some of you. Here are some details:

–diagnosed in Feb 2017, Grade 1 pelvic CS, spread widely on and around the acetabulum. Offered a hemipelvectomy…

September 3rd, 2020

A CS Warrior on the Facebook Chondrosarcoma Support Group entered a new Phase 2 clinical trial yesterday specifically for unresectable and metastatic conventional CS that combines a histone deacetylase inhibitor Belinostat (FDA approved for a type…

September 2nd, 2020

In September, we honor the gold ribbon in recognition of Childhood Cancer Awareness Month! ✨

Did you know cancer is the second leading cause of death in children under the age of 15? In 2020, approximately 11,000 children ages 1-14 will be…

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

clinicaltrials.gov

Brief Summary:
This phase II trial studies how well belinostat and SGI-110…